HIGHLIGHTS
- who: Neville Ng from the Wollongong, New South Wales, Australia University of Wollongong, Northfields Wollongong, New South have published the article: Identification of repurposable cytoprotective drugs in vanishing white matter disease patient-derived cells, in the Journal: (JOURNAL)
- what: The aim of this study was to use fibroblasts and induced pluripotent stem cell (iPSC)-derived astrocytes from patients bearing the EIF2B5R113H/A403V or EIF2B2G200V/E213G VWMD mutations to identify potential repurposable FDA-approved drugs based on in vitro assays. Currently there are no approved treatments for VWMD, hence the aim of this research was to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.